Email ID : 
Password : 
Forgot Your Password ? 

Only Report Titles
Titles & Keywords
NOTE: Site best viewed with Internet Explorer
  URO-GYNECOLOGICAL SURGICAL DEVICES
A Global Strategic Business Report

This report analyzes the worldwide markets for Uro-Gynecological Surgical Devices in US$ Million. The major product segments analyzed are Urological Surgical Devices (Sling & Suspension Devices, & Other Urological Devices), and Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, & Other Gynecological Devices). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia–Pacific, and Rest of World. Annual forecasts are provided for each region for the period of 2001 through 2015. The report profiles 66 companies including many key and niche players worldwide such as Gyrus ACMI Corporation, American Medical Systems Holdings Incorporated, Laserscope, Inc., Boston Scientific Corporation, C. R. Bard, Inc., Cook Urological Inc., CooperSurgical, Inc., Cytyc Corporation, Cytyc Surgical Products, Ethicon Inc., Karl Storz GmbH & Co. KG, MDMI Technologies, Inc., Medtronic, Inc., Olympus America Inc., Olympus Surgical & Industrial America, Inc., Richard Wolf GmbH, and Stryker Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

CODE:    MCP-1554  PAGES:    324
PRICE:    $3950  DATE:       May 2008
COMPANIES:  66  MARKET DATA TABLES:   179
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

 TABLE OF CONTENTS  
  URO-GYNECOLOGICAL SURGICAL DEVICES (Complete Report) Pages : 324   | $3950
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
Quantitative Techniques & Analytics.....I-2
  
   Product Definitions and Scope of Study.....I-3
Urological Surgical Devices.....I-3
Sling & Suspension Devices.....I-3
  
   Other Urological Devices.....I-4
Gynecological Surgical Devices.....I-4
Endometrial Ablation Devices.....I-4
Endoscopes.....I-4
Hysteroscope Systems.....I-4
Fluid Management Systems.....I-4
Other Gynecological Devices.....I-4
  
   Market Outlook.....II-1
Female Demographics & Gynecological Concerns.....II-1
1$100
   Table 1: Percentage Breakdown of Total Female Population Worldwide for Year 2005 (Based on Age Group) (includes corresponding Graph/Chart).....II-2

Table 2: Ovarian Cancer: Global Comparison of Incidence & Mortality Rates by Select Countries (Number per 100,000 women) (includes corresponding Graph/Chart).....II-2
1$400
   Table 3: Uterus Cancer: Global Comparison of Incidence & Mortality Rates by Select Countries (Number per 100,000 population) (includes corresponding Graph/Chart).....II-3

Table 4: Cervical Cancer: Global Comparison of Incidence & Mortality Rates by Select Countries (Number per 100,000 population) (includes corresponding Graph/Chart).....II-3
1$400
   Market Trends & Issues.....II-4
Demand to Enhance with Minimally Invasive Procedures.....II-4
Endometrial Ablation Devices Gaining Prominence.....II-4
Enhancing Market for Urological Surgical Devices.....II-4
Increasing R&D Efforts by Manufacturers.....II-4
1$100
   Regulatory Risk - A Concern for Medical Device Companies.....II-5
Slower Recovery for Older Patients.....II-5
1$100
   Urological Surgical Devices.....II-6
Sling & Suspension Devices.....II-6
Other Urological Surgical Devices.....II-6
Ureteral Stents.....II-6
Gynecological Surgical Devices.....II-6
Endometrial Ablation Devices.....II-6
1$100
   Endoscopes.....II-7
Laparoscope.....II-7
Cystoscope.....II-7
Falloposcope.....II-7
Hysteroscope Systems.....II-7
Fluid Management Systems.....II-7
1$100
   Trocar.....II-8
Tubal Occlusion Systems.....II-8
Curettage Systems.....II-8
Female Pelvic Organs: Select Surgical Procedures.....II-8
Hysteroscopy Procedure.....II-8
1$100
   Laparoscopy Procedure.....II-91$100
   Dilation & Curettage (D&C) Procedure.....II-10
Hysterectomy Procedure.....II-10
2$200
   Myomectomy Procedure.....II-12
Tubal Patency Screening Procedure.....II-12
1$100
   Tubal Ligation Procedure.....II-13
Urethroscopy/Ureteroscopy.....II-13
Electrosurgery.....II-13
A Peek into Women’s Pelvic Health: Surgical Treatments.....II-13
Endometrial Ablation.....II-13
1$100
   Benign-Caused Menorrhagia: Uterine Balloon Therapy (UBT).....II-141$100
   Urinary Incontinence.....II-151$100
   Pelvic Organ Prolapse.....II-16
2$200
   Caldera Gains Rights to Coloplast’s Transobturator Technology.....II-18
Cytyc Merges with Hologic.....II-18
Mistral Pharma and CliniMed Sign Licensing Agreement.....II-18
Cook Medical Forms Distribution Partnership with Gynecor.....II-18
American Medical Systems Divests its Laserscope Aesthetics Business.....II-18
1$100
   Medtronic Initiates Post-Market Study of InterStim Therapy II-18 Cytyc Corporation
  Acquires Adiana.....II-19
Aragon Acquires VeriSure, Inc......II-19
Cytyc Corporation Acquires Endometriosis Treatment Device from Helica.....II-19
1$100
   Teleflex Acquires Taut’s Assets.....II-20
Conceptus Inks Partnerships with Hysteroscope Producers.....II-20
Olympus & Conceptus Ally to Promote Hysteroscopes for Essure®.....II-20
Vision Sciences & Medtronic Terminate Urology Products Distribution Agreement.....II-20
1$100
   Synovis Inks Distribution Agreement with Caldera for Hydrix XM.....II-21
AMS Acquires Laserscope.....II-21
C. R. Bard Takes Over Venetec International.....II-21
1$100
   ETHICON Acquires Vascular Control Systems.....II-22
AMS Purchases Urology Technology of BioControl Medical.....II-22
Laserscope Takes Over InnovaQuartz, Inc......II-22
ACMI Corporation Signs an Agreement with MMS.....II-22
1$100
   AMS Forms Cross-Licensing Deal with Caldera Medical.....II-23
Mentor Divests Urology Business.....II-23
Gyrus Group Acquires ACMI.....II-23
C. R. Bard Acquired Select Assets from Genyx Medical.....II-23
Caldera Medical Forms Alliance with MTF.....II-23
1$100
   Conceptus Signs Partnership Agreements .....II-24
Uroplasty Receives Approval for Urgent® PC Urological Device.....II-24
Uroplasty Receives USFDA Approval.....II-24
Cooper Surgical Steps into Gynecologic Surgery Market.....II-24
1$100
   Conceptus Terminates Deal Signed with Gynecare.....II-25
Cytyc Corporation Acquires Novacept.....II-25
AMS Acquires CryoGen.....II-25
1$100
   Gyrus ACMI Launches New Endoscope Protection System.....II-26
Aragon Surgical Introduces a New LapCap Laparoscopic Device.....II-26
American Medical Systems Introduces MiniArc™ System.....II-26
Gyrus ACMI Unveils DUR-D Digital Flexible Ureteroscope.....II-26
1$100
   Ethicon Launches GYNECARE TVT SECUR™ System for SUI Treatment.....II-27
Ethicon Unveils GYNECARE MORCELLEX Tissue Morcellator Device.....II-27
Medtronic Gains FDA & CE Mark Approvals for its InterStim® II System.....II-27
1$100
   FDA Approves Use of Ethicon’s Harmonic Wave for Open Surgical Procedures.....II-28
Caldera Adds New Prolapse Indication for T-Sling.....II-28
FDA Approves Colpexin Sphere Device for Prolapse Support.....II-28
Laserscope Unveils GreenLight HPS.....II-28
1$100
   New Mini-Hysteroscope from Blue Endo.....II-29
POPmesh™ from Caldera Medical.....II-29
Olympus Introduces New Endoscopes.....II-29
All-Digital Flexible Endoscope from ACMI.....II-29
1$100
   Gyrus ACMI Corporation (USA).....II-30
American Medical Systems Holdings Incorporated (USA).....II-30
Laserscope, Inc. (USA).....II-30
1$100
   Boston Scientific Corporation (USA).....II-311$100
   C. R. Bard, Inc. (USA).....II-32
Cook Urological Inc. (USA).....II-32
CooperSurgical, Inc. (USA).....II-32
Cytyc Corporation (USA).....II-32
1$100
   Cytyc Surgical Products.....II-33
Ethicon Inc. (USA).....II-33
Karl Storz GmbH & Co. KG (Germany).....II-33
MDMI Technologies, Inc. (Canada).....II-33
1$100
   Medtronic, Inc. (USA).....II-34
Olympus America Inc. (USA).....II-34
Olympus Surgical & Industrial America, Inc. (USA).....II-34
1$100
   Richard Wolf GmbH (Germany).....II-35
Stryker Corporation (USA).....II-35
1$100
   Table 5: World Recent Past, Current and Future Analysis for Uro-Gynecological Surgical Devices by Geographic Region – US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), and Rest of World Markets Independently Analyzed by Annual Sales in US$ Million for the Years 2001 through 2010 (includes corresponding Graph/Chart).....II-361$400
   Table 6: World Long-term Projections for Uro-Gynecological Surgical Devices by Geographic Region – US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), and Rest of World Markets Independently Analyzed by Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-371$400
   Table 7: World 10-Year Perspective for Uro-Gynecological Surgical Devices by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia Pacific (excluding Japan), and Rest of World Markets for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....II-381$400
   Table 8: World Recent Past, Current and Future Analysis for Urological Surgical Devices by Geographic Region – US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), and Rest of World Markets Independently Analyzed by Annual Sales in US$ Million for the Years 2001 through 2010 (includes corresponding Graph/Chart).....II-391$400
   Table 9: World Long-term Projections for Urological Surgical Devices by Geographic Region – US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), and Rest of World Markets Independently Analyzed by Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-401$400
   Table 10: World 10-Year Perspective for Urological Surgical Devices by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia Pacific (excluding Japan), and Rest of World Markets for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....II-411$400
   Table 11: World Recent Past, Current and Future Analysis for Urological Surgical Devices by Product Segment– Sling & Suspension Devices and Other Urological Devices Markets Independently Analyzed by Annual Sales in US$ Million for the Years 2001 through 2010 (includes corresponding Graph/Chart).....II-42

Table 12: World Long-term Projections for Urological Surgical Devices by Product Segment – Sling & Suspension Devices and Other Urological Devices Markets Independently Analyzed by Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-42
1$400
   Table 13: World 10-Year Perspective for Urological Surgical Devices by Product Segment– Sling & Suspension Devices and Other Urological Devices Markets for the Years 2003, 2008 and 2012.....II-431$400
   Table 14: World Recent Past, Current and Future Analysis for Sling & Suspension Devices by Geographic Region – US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), and Rest of World Markets Independently Analyzed by Annual Sales in US$ Million for the Years 2001 through 2010 (includes corresponding Graph/Chart).....II-441$400
   Table 15: World Long-term Projections for Sling & Suspension Devices by Geographic Region – US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), and Rest of World Markets Independently Analyzed by Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-451$400
   Table 16: World 10-Year Perspective for Sling & Suspension Devices by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia Pacific (excluding Japan), and Rest of World Markets for the Years 2003, 2008 and 2012 (includecorresponding Graph/Chart).....II-461$400
   Table 17: World Recent Past, Current and Future Analysis for Other Urological Devices by Geographic Region – US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), and Rest of World Markets Independently Analyzed by Annual Sales in US$ Million for the Years 2001 through 2010 (includes corresponding Graph/Chart).....II-471$400
   Table 18: World Long-term Projections for Other Urological Devices by Geographic Region – US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), and Rest of World Markets Independently Analyzed by Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-481$400
   Table 19: World 10-Year Perspective for Other Urological Devices by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia Pacific (excluding Japan), and Rest of World Markets for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....II-491$400
   Table 20: World Recent Past, Current and Future Analysis for Gynecological Surgical Devices by Geographic Region – US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), and Rest of World Markets Independently Analyzed by Annual Sales in US$ Million for the Years 2001 through 2010 (includes corresponding Graph/Chart).....II-501$400
   Table 21: World Long-term Projections for Gynecological Surgical Devices by Geographic Region – US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), and Rest of World Markets Independently Analyzed by Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-511$400
   Table 22: World 10-Year Perspective for Gynecological Surgical Devices by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia Pacific (excluding Japan), and Rest of World Markets for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....II-521$400
   Table 23: World Recent Past, Current and Future Analysis for Gynecological Surgical Devices by Product Segment– Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices Markets Independently Analyzed by Annual Sales in US$ Million for the Years 2001 through 2010 (includes corresponding Graph/Chart).....II-53

Table 24: World Long-term Projections for Gynecological Surgical Devices by Product Segment– Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices Markets Independently Analyzed by Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-53
1$400
   Table 25: World 10-Year Perspective for Gynecological Surgical Devices by Product Segment– Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices Markets for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....II-541$400
   Table 26: World Recent Past, Current and Future Analysis for Endometrial Ablation Devices by Geographic Region – US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), and Rest of World Markets Independently Analyzed by Annual Sales in US$ Million for the Years 2001 through 2010 (includes corresponding Graph/Chart).....II-551$400
   Table 27: World Long-term Projections for Endometrial Ablation Devices by Geographic Region – US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), and Rest of World Markets Independently Analyzed by Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-561$400
   Table 28: World 10-Year Perspective for Endometrial Ablation Devices by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe,Asia Pacific (excluding Japan), and Rest of World Markets for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....II-571$400
   Table 29: World Recent Past, Current and Future Analysis for Endoscopes by Geographic Region – US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), and Rest of World Markets Independently Analyzed by Annual Sales in US$ Million for the Years 2001 through 2010 (includes corresponding Graph/Chart).....II-581$400
   Table 30: World Long-term Projections for Endoscopes by Geographic Region – US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), and Rest of World Markets Independently Analyzed by Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-591$400
   Table 31: World 10-Year Perspective for Endoscopes by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia Pacific (excluding Japan), and Rest of World Markets for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....II-601$400
   Table 32: World Recent Past, Current and Future Analysis for Hysteroscope Systems by Geographic Region – US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), and Rest of World Markets Independently Analyzed by Annual Sales in US$ Million for the Years 2001 through 2010 (includes corresponding Graph/Chart).....II-611$400
   Table 33: World Long-term Projections for Hysteroscope Systems by Geographic Region – US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), and Rest of World Markets Independently Analyzed by Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-621$400
   Table 34: World 10-Year Perspective for Hysteroscope Systems by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia Pacific (excluding Japan), and Rest of World Markets for the Years2003, 2008 and 2012 (includes corresponding Graph/Chart).....II-631$400
   Table 35: World Recent Past, Current and Future Analysis for Fluid Management Systems by Geographic Region – US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), and Rest of World Markets Independently Analyzed by Annual Sales in US$ Million for the Years 2001 through 2010 (includes corresponding Graph/Chart).....II-641$400
   Table 36: World Long-term Projections for Fluid Management Systems by Geographic Region – US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), and Rest of World Markets Independently Analyzed by Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-651$400
   Table 37: World 10-Year Perspective for Fluid Management Systems by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia Pacific (excluding Japan), and Rest of World Markets for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....II-661$400
   Table 38: World Recent Past, Current and Future Analysis for Other Gynecological Devices by Geographic Region – US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), and Rest of World Markets Independently Analyzed by Annual Sales in US$ Million for the Years 2001 through 2010 (includes corresponding Graph/Chart).....II-671$400
   Table 39: World Long-term Projections for Other Gynecological Devices by Geographic Region – US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), and Rest of World Markets Independently Analyzed by Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-681$400
   Table 40: World 10-Year Perspective for Other Gynecological Devices by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia Pacific (excluding Japan), and Rest of World Markets for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....II-691$400
   A. Market Analysis.....III-1
Female Demographics.....III-1
Table 41: Percentage Breakdown of Female Population in the US by Age Group: 2007 (includes corresponding Graph/Chart).....III-1
Current Scenario in the US Gynecological Devices Market.....III-1
1$250
   Table 42: Number of GEA Procedures (2005-2007) in the US (includes corresponding Graph/Chart).....III-2
Major Trends & Issues.....III-2
Increasing Acceptance of Alternative Procedures to Hysterectomy.....III-2
Bright Prospects for Urological Surgical Devices.....III-2
1$250
   Least-Invasive Surgical Procedures Drive the US Market.....III-3
Demographics to Play a Major Role.....III-3
Table 43: Prevalence of Various Urological Disorders in Females over 65 Years (includes corresponding Graph/Chart).....III-3
Gynecological Disorders in US Women.....III-3
1$250
   Table 44: Gynecological Cancer in the US: Incidence & Mortality Rates of Various Cancersfor the Year 2005 (includes corresponding Graph/Chart).....III-4

Table 45: Gynecological Cancer in the US: Number of New Cancer Cases Diagnosed for the Year 2004 (includes corresponding Graph/Chart).....III-4
1$250
   Table 46: Cervical Cancer in the US: Comparison of Incidence & Mortality Rates by Select Race/Ethnicity for Year 2002 (includes corresponding Graph/Chart).....III-5

Table 47: Select Surgical Procedures Performed in the US for the Year 2005 (Procedures in Thousand).....III-5
Hysterectomy in the United States.....III-5
1$250
   Major Reasons for Hysterectomy Procedures in the US (Based on Age Group).....III-6
Table 48: Hysterectomy Procedures in the US - Percentage Breakdown by Causes/Disorders (includes corresponding Graph/Chart).....III-6

Table 49: US Recent Past, Current and Future Analysis for Hysterectomy by Procedure Types – Abdominal Hysterectomy, and Vaginal Hysterectomy Independently Analyzed by Procedure Number in Thousand for the Years 2001 through 2010 (includes corresponding Graph/Chart).....III-6
1$250
   Table 50: US Recent Past, Current and Future Analysis for Hysteroscopy by Procedure Types –Diagnostic Hysteroscopy, and Operative Hysteroscopy Independently Analyzed by Procedure Number in Thousand for the Years 2001 through 2010 (includes corresponding Graph/Chart).....III-7
Glimpse of Medicare Reimbursements in the US.....III-7
Table 51: Medicare Reimbursements for Hysterectomy Procedures for the Year 2005.....III-7
1$250
   Table 52: Medicare Reimbursements for Endometrial Ablation Procedures for the Year 2005.....III-8

Table 53: Medicare Reimbursements for Vaginal Vault Support (AVESTA® Procedure) for the Year 2005.....III-8
1$250
   Table 54: Medicare Reimbursements for Uterine Suspension (UPLIFT Procedure) for the Year 2005.....III-9

Table 55: Medicare Reimbursements for Uterine Prolapse Repair (ELEVEST® Procedure) for the Year 2005.....III-9
Major Players.....III-9
1$250
   Table 56: US Market for Sling Systems: Market Shares of Major Players - Johnson & Johnson, American Medical Systems, Boston Scientific Corporation, C.R. Bard, Inc, Cook Urological Inc Mentor Corporation, and Others for the Years 2004 & 2005 (includes corresponding Graph/Chart).....III-10

Table 57: US Market for Suspension Systems: Market Shares of Major Players - Boston Scientific Corporation, C.R. Bard, Inc, CooperSurgical, Inc, and Others for the Years 2005 & 2006 (includes corresponding Graph/Chart).....III-10
1$250
   Table 58: US Market for Ablation Systems: Market Shares of Major Players - American Medical Systems, Boston Scientific Corporation, Johnson & Johnson, Microsulis, and Others for the Years 2005 & 2006 (includes corresponding Graph/Chart).....III-11

Table 59: US Market for Endoscopic Products: Market Shares of Major Players – ACMI, Johnson & Johnson, Karl Storz Endoscope-America, Inc, Richard Wolf Instruments, United States Surgical, and Others for the Years 2005 & 2006 (includes corresponding Graph/Chart).....III-11
1$250
   Table 60: US Market for Hysteroscope Systems: Market Shares of Major Players – ACMI, CooperSurgical, Inc, Johnson & Johnson, and Others for the Years 2005 & 2006 (includes corresponding Graph/Chart).....III-12

Table 61: US Market for Fluid Management Systems: Market Shares of Major Players – ACMI, American Medical Systems, Johnson & Johnson, and Others for the Years 2005 & 2006 (includes corresponding Graph/Chart).....III-12
1$250
   Table 62: US Market for Other Gynecological Products: Market Shares of Major Players – ACMI, American Medical Systems, Boston Scientific Corporation, Cooper Surgical, Inc, United States Surgical, and Others for the Years 2005 & 2006 (includes corresponding Graph/Chart).....III-13
Select Products from Major US Companies in Respective Market Segments.....III-13
1$250
   Strategic Corporate Developments.....III-147$375
   Product Launches.....III-214$300
   Key Players.....III-255$375
   B. Market Analytics.....III-30
Table 63: US Recent Past, Current and Future Analysis for Uro-Gynecological Surgical Devices by Product Group/Segment – Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets Independently Analyzed by Annual Sales in US$ Million for the Years 2001 through 2010 (includes corresponding Graph/Chart).....III-30
1$250
   Table 64: US Long-term Projections for Uro-Gynecological Surgical Devices by Product Group/Segment – Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-311$250
   Table 65: US 10-Year Perspective for Uro-Gynecological Surgical Devices by Product Group/Segment – Percentage Breakdown of Dollar Sales for Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets forthe Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....III-32
1$250
   A. Market Analysis.....III-33
Market Overview.....III-33
Female Demographics.....III-33
Table 66: Percentage Breakdown of Female Population in Canada by Age Group: 2006 (includes corresponding Graph/Chart).....III-33

Table 67: Number of New Gynecological Cancer Cases Diagnosed in Canada in 2004.....III-33
1$250
   Strategic Corporate Development.....III-34
MDMI Technologies Inc. – A Key Player.....III-34
1$75
   B. Market Analytics.....III-35
Table 68: Canadian Recent Past, Current and Future Analysis for Uro-Gynecological Surgical Devices by Product Group/Segment – Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets Independently Analyzed by Annual Sales in US$ Million for the Years 2001 through 2010 (includes corresponding Graph/Chart).....III-35
1$250
   Table 69: Canadian Long-term Projections for Uro-Gynecological Surgical Devices by Product Group/ Segment – Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-361$250
   Table 70: Canadian 10-Year Perspective for Uro-Gynecological Surgical Devices by Product Group/ Segment – Percentage Breakdown of Dollar Sales for Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....III-37
1$250
   A. Market Analysis.....III-38
Market Overview.....III-38
Female Demographics.....III-38
Table 71: Percentage Breakdown of Female Population in Japan by Age Group: 2007 (includes corresponding Graph/Chart).....III-38
1$250
   B. Market Analytics.....III-39
Table 72: Japanese Recent Past, Current and Future Analysis for Uro-Gynecological Surgical Devices by Product Group/Segment – Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets Independently Analyzed by Annual Sales in US$ Million for the Years 2001 through 2010 (includes corresponding Graph/Chart).....III-39
1$250
   Table 73: Japanese Long-term Projections for Uro-Gynecological Surgical Devices by Product Group/Segment – Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-401$250
   Table 74: Japanese 10-Year Perspective for Uro-Gynecological Surgical Devices by Product Group/Segment – Percentage Breakdown of Dollar Sales for Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems,Fluid Management Systems, and Other Gynecological Devices) Markets for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....III-41
1$250
   A. Market Analysis.....III-42
Market Overview.....III-42
Female Demographics.....III-42
Table 75: Percentage Breakdown of Total Female Population of European Union for the Year 2005 (Based on Age Group) (includes corresponding Graph/Chart).....III-42
1$250
   Table 76: Percentage Breakdown of Total Female Population of European Union for the Year 2005 by Member Countries (Based on Age Group).....III-43
Gynecological Cancer Statistics.....III-43
1$250
   Table 77: Mortality Rate of Cervical Cancer in Select European Regions for the Year 2000 (Number per 100,000 women) (includes corresponding Graph/Chart).....III-44
Current Scenario in the European Gynecological Devices Market.....III-44
1$250
   B. Market Analytics.....III-45
Table 78: European Recent Past, Current and Future Analysis for Uro-Gynecological Gynecological Devices by Geographic Region – France, Germany, UK, Italy, and Rest of Europe Markets Independently Analyzed by Annual Sales in US$ Million for the Years 2001 through 2010 (includes corresponding Graph/Chart).....III-45
1$250
   Table 79: European Long-term Projections for Uro-Gynecological Devices by Geographic Region – France, Germany, UK, Italy, and Rest of Europe Markets Independently Analyzed by Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-461$250
   Table 80: European Recent Past, Current and Future Analysis for Uro-Gynecological Surgical Devices by Product Group/Segment – Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets Independently Analyzed by Annual Sales in US$ Million for the Years 2001 through 2010 (includes corresponding Graph/Chart).....III-471$250
   Table 81: European Long-term Projections for Uro-Gynecological Surgical Devices by Product Group/Segment – Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-481$250
   Table 82: European 10-Year Perspective for Uro- Gynecological Devices by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, UK, Italy, and Rest of Europe Markets for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....III-491$250
   Table 83: European 10-Year Perspective for Uro-Gynecological Surgical Devices by Product Group / Segment – Percentage Breakdown of Dollar Sales for Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....III-50
1$250
   A. Market Analysis.....III-51
Market Overview.....III-51
Female Demographics.....III-51
Table 84: Percentage Breakdown of Female Population in France by Age Group: 2007 (includes corresponding Graph/Chart).....III-51
Select Diagnostic Procedures Performed in France in 2005.....III-51
1$250
   B. Market Analytics.....III-52
Table 85: French Recent Past, Current and Future Analysis for Uro-Gynecological Surgical Devices by Product Group/Segment – Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets Independently Analyzed by Annual Sales in US$ Million for the Years 2001 through 2010 (includes corresponding Graph/Chart).....III-52
1$250
   Table 86: French Long-term Projections for Uro-Gynecological Surgical Devices by Product Group/ Segment – Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-531$250
   Table 87: French 10-Year Perspective for Uro-Gynecological Surgical Devices by Product Group/ Segment – Percentage Breakdown of Dollar Sales for Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems,Fluid Management Systems, and Other Gynecological Devices) Markets for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....III-54
1$250
   A. Market Analysis.....III-55
Market Overview.....III-55
Female Demographics.....III-55
Table 88: Percentage Breakdown of Female Population in Germany by Age Group: 2007 (includes corresponding Graph/Chart).....III-55
Select Diagnostic Procedures Performed in Germany in 2005.....III-55
Key Players.....III-55
1$250
   B. Market Analytics.....III-56
Table 89: German Recent Past, Current and Future Analysis for Uro-Gynecological Surgical Devices by ProductGroup/ Segment – Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets Independently Analyzed by Annual Sales in US$ Million for the Years 2001 through 2010 (includes corresponding Graph/Chart).....III-56
1$250
   Table 90: German Long-term Projections for Uro-Gynecological Surgical Devices by Product Group/ Segment – Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-571$250
   Table 91: German 10-Year Perspective for Uro- Gynecological Surgical Devices by Product Group/ Segment – Percentage Breakdown of Dollar Sales for Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....III-58
1$250
   A. Market Analysis.....III-59
Market Overview.....III-59
Female Demographics.....III-59
Table 92: Percentage Breakdown of Female Population in the UK for Year 2007 (Based on Age Group) (includes corresponding Graph/Chart).....III-59
Select Diagnostic Procedures Performed in the UK in 2005.....III-59
UK Gynecological Cancer Market.....III-59
1$250
   Table 93: Mortality Rates of Gynecological Cancer Cases in the UK in 2004.....III-60

Table 94: Number of Gynecological Cancer Cases Diagnosed in the UK in 2002 (includes corresponding Graph/Chart).....III-60
New UK NICE Clinical Guidelines Promote Endometrial Ablation for HMB.....III-60
1$250
   Embolisation – Ideal Alternative to Hysterectomy Procedures.....III-61
Strategic Corporate Developments.....III-61
1$75
   Femcare-Nikomed Ltd – A Key Player.....III-621$75
   B. Market Analytics.....III-63
Table 95: UK Recent Past, Current and Future Analysis for Uro-Gynecological Surgical Devices by Product Group/ Segment – Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets Independently Analyzed by Annual Sales in US$ Million for the Years 2001 through 2010 (includes corresponding Graph/Chart).....III-63
1$250
   Table 96: UK Long-term Projections for Uro- Gynecological Surgical Devices by Product Group/ Segment – Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-641$250
   Table 97: UK 10-Year Perspective for Uro- Gynecological Surgical Devices by Product Group/Segment – Percentage Breakdown of Dollar Sales for Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....III-65
1$250
   A. Market Analysis.....III-66
Market Overview.....III-66
Female Demographics.....III-66
Table 98: Percentage Breakdown of Female Population in Italy by Age Group: 2007 (includes corresponding Graph/Chart).....III-66
Select Diagnostic Procedures Performed in Italy in 2005.....III-66
1$250
   B. Market Analytics.....III-67
Table 99: Italian Recent Past, Current and Future Analysis for Uro-Gynecological Surgical Devices by Product Group/Segment – Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets Independently Analyzed by Annual Sales in US$ Million for the Years 2001 through 2010 (includes corresponding Graph/Chart).....III-67
1$250
   Table 100: Italian Long-term Projections for Uro-Gynecological Surgical Devices by Product Group/ Segment – Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-681$250
   Table 101: Italian 10-Year Perspective for Uro-Gynecological Surgical Devices by Product Group/Segment – Percentage Breakdown of Dollar Sales for Urological Surgical Devices (Sling & SuspensionDevices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....III-69
1$250
   Market Analysis.....III-70
Table 102: Rest of Europe Recent Past, Current and Future Analysis for Uro-Gynecological Surgical Devices by Product Group/Segment – Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets Independently Analyzed by Annual Sales in US$ Million for the Years 2001 through 2010 (includes corresponding Graph/Chart).....III-70
1$250
   Table 103: Rest of Europe Long-term Projections for Uro-Gynecological Surgical Devices by Product Group/Segment – Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-711$250
   Table 104: Rest of Europe 10-Year Perspective for Uro-Gynecological Surgical Devices by Product Group / Segment – Percentage Breakdown of Dollar Sales for Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....III-72
1$250
   A. Market Analysis.....III-73
Market Overview.....III-73
Table 105: Percentage Breakdown of Total Female Population for Select Asian Countries for the Year 2007 (Based on Age Group).....III-73
Glance at Chinese and Indian Markets.....III-73
1$250
   A Peek Into Australian Market.....III-74
Table 106: Incidence Rates of Gynecological Cancer in Australia for the Year 2005 (includes corresponding Graph/Chart).....III-74

Table 107: Mortality Rates of Gynecological Cancer in Australia for the Year 2004 (includes corresponding Graph/Chart).....III-74
1$250
   Table 108: Risk of Developing Gynecological Cancer Among Australian Women.....III-75
B. Market Analytics.....III-75
Table 109: Asia Pacific Recent Past, Current and Future Analysis for Uro-Gynecological Surgical Devices by Product Group/Segment – Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets Independently Analyzed by Annual Sales in US$ Million for the Years 2001 through 2010 (includes corresponding Graph/Chart).....III-75
1$250
   Table 110: Asia-Pacific Long-term Projections for Uro-Gynecological Surgical Devices by Product Group/ Segment – Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-761$250
   Table 111: Asia Pacific 10-Year Perspective for Uro-Gynecological Surgical Devices by Product Group/ Segment – Percentage Breakdown of Dollar Sales for Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....III-77
1$250
   A. Market Analysis.....III-78
Strategic Corporate Developments.....III-78
1$75
   B. Market Analytics.....III-79
Table 112: Rest of World Recent Past, Current and Future Analysis for Uro-Gynecological Surgical Devices by Product Group/Segment – Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets Independently Analyzed by Annual Sales in US$ Million for the Years 2001 through 2010 (includes corresponding Graph/Chart).....III-79
1$250
   Table 113: Rest of World Long-term Projections for Uro-Gynecological Surgical Devices by Product Group/Segment – Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-801$250
   Table 114: Rest of World 10-Year Perspective for Uro-Gynecological Surgical Devices by Product Group /Segment – Percentage Breakdown of Dollar Sales for Urological Surgical Devices (Sling & Suspension Devices, and Other Urological Devices), Gynecological Surgical Devices (Endometrial Ablation Devices, Endoscopes, Hysteroscope Systems, Fluid Management Systems, and Other Gynecological Devices) Markets for the Years2003, 2008 and 2012 (includes corresponding Graph/Chart).....III-811$250
  
Total Companies Profiled: 66 (including Division/Subsidiaries - 81)

Region/Country Players

The United States 55 Canada 1 Japan 1 Europe 15 France 2 Germany 6 The United Kingdom 5 Rest of Europe 2 Asia-Pacific (Excluding Japan) 8 Middle East 1
Click here to request a full table of contents and more details on this project.
  
 
 
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

© Copyrights 2010, Global Industry Analysts, Inc., USA.